P1.185. Health-Related Quality of Life After Robot-Assisted Versus Thoracoscopic Esophagectomy: A Secondary Analysis From the Multicenter RAMIE Trial

Clicks: 19
ID: 326075
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #220 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background The comparative effects of robot-assisted and thoracoscopic esophagectomy on postoperative health-related quality of life (HRQOL) are not well defined. Here, we sought to assess patient-reported HRQOL outcome following robot-assisted versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma (ESCC). Methods This prespecified secondary analysis utilized data from the multicenter, randomized RAMIE trial (NCT03094351), including patients with ESCC who underwent curative McKeown esophagectomy. Participants were randomly assigned to receive either robot-assisted or thoracoscopic esophagectomy were monitored prospectively for HRQOL outcomes using the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-OES18 questionnaires administered at baseline and at 1, 3, and 12 months postoperatively. Longitudinal patterns were examined using generalized estimating equations. Results The per-protocol analysis included 358 patients (robot-assisted group, n = 181; thoracoscopic group, n = 177). Following esophagectomy, robot-assisted surgery showed improved efficiency of thoracic lymph node dissection in patients who received neoadjuvant therapy (15 vs 12, P = 0.016), as well as higher achievement rate of lymph node dissection along the left recurrent laryngeal nerve (79.5% vs 67.6%, P = 0.001). Overall, both cohorts showed a temporary decline in several HRQOL domains. The mean scores for global health status at baseline and at 1, 3, and 12 months postoperatively were comparable. Regarding the variable of “trouble talking”, both groups exhibited moderate worsening at 1 month postoperatively and returned to baseline levels at 3 months. Each functional and symptom scale in the QLQ-C30 and QLQ-OES18 questionnaires demonstrated no significant difference over time between the two groups. Conclusion There were no clear HRQOL benefits of robot-assisted over thoracoscopic esophagectomy. However, robot-assisted esophagectomy conferred several perioperative benefits.
Reference Key
openalex_W7203981753 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.333
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.